Senior development engineering, not junior throughput
The engineers on the sprint have run device development across catheter-based and Class II and Class III programs. The person doing the design work is the person you meet at the review.
Design 10x
Senior device design engineering with AI running through every step — and a working prototype in your hand at the end of it, not a render.
AI-drafted · evidence-cited · human-reviewed
The engineers on the sprint have run device development across catheter-based and Class II and Class III programs. The person doing the design work is the person you meet at the review.
Prototyping and machining are in-house. That is why a sprint ends with a part you can hold and test rather than a render you have to imagine, and why the turnaround does not depend on a supplier queue.
AI widens the concept set, drafts the requirement and test-plan structure, and does the tedious cross-checking. Every deliverable carries a named human reviewer who signed it, and the review record says what they changed.
DES-01
Your intended use, constraints, and whatever requirements exist. The review is where we agree the scope, quote it, and tell you if this is not a sprint we should take.
DES-02
A deliberately wide set of concepts generated against the requirements, then narrowed by engineers on manufacturability, risk, and the pathway — with the reasoning written down.
DES-03
The surviving concept goes to CAD and then to the machines. You see the design before it is cut, and you get the files as well as the part.
DES-04
A first bench characterisation against the requirements, and a design review record your quality system can file rather than reconstruct later.
The offer
This is a new service line and we are pricing it to learn: a fixed fee, quoted within 48 hours of the scoping review, for a single concept or subsystem.
Intake is limited. A sprint occupies a senior design engineer and machine time for four to six weeks, and neither parallelises, so we run a small number concurrently. If the concept is larger than one subsystem, or if it is not one we can do well, we say so at the review rather than after an SOW.
Three smaller engagements exist for teams that do not need a full sprint: a fixed-price DFM and design review, one to two weeks; a prototype sprint for engineering teams that have the design and need the parts; and a fractional senior design engineer for programs that need the seniority without the headcount. All three are quoted the same way, after a review.
AI-drafted · evidence-cited · human-reviewed
Capabilities we deliver that do not have their own page yet. No prices and no lead times here — those belong to an engagement, and an engagement starts with a review.
FEA, CFD, and CT-based analysis, with the credibility evidence structured to ASME V&V 40 and to what FDA expects of computational modelling in a submission.
End-of-line inspection stations, with the vision models running on hardware inside your building, delivered with the TMV documentation that makes the station audit-ready.
Automation roadmaps, line concepting, and data-first yield and throughput analysis built from your existing historian and MES exports.
Our document-analysis and inspection tooling runs entirely on hardware you control. No client data leaves your building.
How local AI works →Limited intake
What happens in each of the four to six weeks, what you receive, and what we need from you at the review.
It widens and it drafts. AI generates a far larger concept set than a person would sketch in the time available, drafts requirement and test-plan structure, and cross-checks documents against each other. What it never does is decide: which concept survives, whether a risk control is adequate, whether a material is appropriate, and whether the design is ready to move on are engineering judgements made by a named person who signs for them. If a deliverable cannot be traced to a human who reviewed it, it does not leave.
You do. Anything created for you in the sprint — concepts, CAD, drawings, the prototype — is yours, and that is written into the statement of work rather than implied by a terms page. We keep only the limited licence needed to do the work you engaged us for. If you are working under an institutional or investor agreement that touches IP, tell us at the review so it is handled before anything is drawn.
A machined part or assembly in a representative material, with real geometry and real tolerances, suitable for bench characterisation and for putting in a clinician’s hand. It is not sterile, not validated, and not for use in or on a patient. If your concept needs a material or process we cannot machine in-house, we say so at the review and quote the supplier route honestly rather than absorbing it silently.
Deliberately. The sprint produces requirements and a test plan in the structure the V&V line scans and the documentation line builds from, so nothing is retyped or reconstructed at the handoff. You are not obliged to use either — the outputs are yours and they are standard artefacts — but if you do, the second engagement starts from a file that is already in the right shape.
Yes, for the document and analysis side. Our document-analysis tooling can run on hardware you control, so drawings, requirements, and design files never leave your network. CAD and machining obviously involve moving files to us under the confidentiality terms in the SOW; what the local option removes is the AI-processing layer as a separate place your data would otherwise sit. We will tell you exactly which steps run where before you sign.
Then the sprint says so, with the reasoning written down, and that is a result worth having for a fixed fee in six weeks rather than a year. Sometimes the honest output is a different concept than the one you arrived with; sometimes it is that the requirement everyone assumed was fixed is the thing that needs to move.